MOVERS & SHAKERS
5/11/18: Dr. Rothman retired recently from his position as Vice President of medical affairs for coronary, structural heart and renal denervation, for Medtronic, based in Santa Rosa (CA), a position he held since 2010. He was involved in the development of the renal denervation program, TAVR, and the Medtronic percutaneous mitral regurgitation program, including Twelve and development of its Intrepid TMVR product and associated clinical strategy.
5/11/18: Most recently, Ms. Sainz was President and CEO of Cardiokinetix, a medical device company that developed a novel treatment for heart failure. Prior to Cardiokinetix, Ms. Sainz was President and CEO of Concentric Medical where she led the commercialization of the company’s MERCI system and successfully negotiated its sale to Stryker Corporation in 2012.
5/11/12: The company is on-track to achieve key clinical and regulatory milestones.
EchoNous Names Point-of-Care Ultrasound Leader and Educational Pioneer Michael Blaivas, M.D., MBA, as Chief Medical Officer
5/10/18: An “original” POCUS user and educator in emergency medicine since 1993.